Literature DB >> 27933781

Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets.

Holly Freedman1, Michael R Logan1, John Lok Man Law1, Michael Houghton1.   

Abstract

The hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are critical in viral attachment and cell fusion, and studies of these proteins may provide valuable insights into their potential uses in vaccines and antiviral strategies. Progress has included elucidating the crystal structures of portions of their ectodomains, as well as many other studies of hypervariable regions, stem regions, glycosylation sites, and the participation of E1/E2 in viral fusion with the endosomal membrane. The available structural data have shed light on the binding sites of cross-neutralizing antibodies. A large amount of information has been discovered concerning heterodimerization, including the roles of transmembrane domains, disulfide bonding, and heptad repeat regions. The possible organization of higher order oligomers within the HCV virion has also been evaluated on the basis of experimental data. In this review, E1/E2 structure and function is discussed, and some important issues requiring further study are highlighted.

Entities:  

Keywords:  E1/E2 heterodimer; envelope glycoprotein; hepatitis C virus; hypervariable region; neutralizing antibody; viral fusion protein

Mesh:

Substances:

Year:  2016        PMID: 27933781     DOI: 10.1021/acsinfecdis.6b00110

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  14 in total

1.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.

Authors:  Andrew I Flyak; Stormy Ruiz; Michelle D Colbert; Tiffany Luong; James E Crowe; Justin R Bailey; Pamela J Bjorkman
Journal:  Cell Host Microbe       Date:  2018-11-14       Impact factor: 21.023

Review 3.  Designing an HCV vaccine: a unique convergence of prevention and therapy?

Authors:  Christopher M Walker
Journal:  Curr Opin Virol       Date:  2017-05-25       Impact factor: 7.090

4.  Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy.

Authors:  Oleg Kurtenkov; Jelena Jakovleva; Boris Sergejev; Julia Geller
Journal:  Dis Markers       Date:  2020-06-23       Impact factor: 3.434

5.  Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous Clearance.

Authors:  Sivan Eliyahu; Oz Sharabi; Shiri Elmedvi; Reut Timor; Ateret Davidovich; Francois Vigneault; Chris Clouser; Ronen Hope; Assy Nimer; Marius Braun; Yaacov Y Weiss; Pazit Polak; Gur Yaari; Meital Gal-Tanamy
Journal:  Front Immunol       Date:  2018-12-21       Impact factor: 7.561

6.  Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus.

Authors:  Dmitry Polyakov; Ekaterina Sinitsyna; Natalia Grudinina; Mariia Antipchik; Rodion Sakhabeev; Viktor Korzhikov-Vlakh; Mikhail Shavlovsky; Evgenia Korzhikova-Vlakh; Tatiana Tennikova
Journal:  Pharmaceutics       Date:  2021-05-07       Impact factor: 6.321

Review 7.  Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity.

Authors:  Nicholas A Brasher; Anurag Adhikari; Andrew R Lloyd; Nicodemus Tedla; Rowena A Bull
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

Review 8.  Structural perspectives on HCV humoral immune evasion mechanisms.

Authors:  Madhumati Sevvana; Zhenyong Keck; Steven Kh Foung; Richard J Kuhn
Journal:  Curr Opin Virol       Date:  2021-06-03       Impact factor: 7.121

Review 9.  Mechanisms of HCV resistance to broadly neutralizing antibodies.

Authors:  Nicole Frumento; Andrew I Flyak; Justin R Bailey
Journal:  Curr Opin Virol       Date:  2021-07-28       Impact factor: 7.121

Review 10.  Hepatitis C virus infection and tight junction proteins: The ties that bind.

Authors:  Laurent Mailly; Thomas F Baumert
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-04-05       Impact factor: 4.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.